Leukaemia Care online store
Liposomal daunorubicin and cytarabine for acute myeloid leukaemia (AML)
Liposomal daunorubicin and cytarabine for acute myeloid leukaemia (AML)
Regular price
£0.00 GBP
Regular price
Sale price
£0.00 GBP
Unit price
per
Tax included.
Couldn't load pickup availability
This leaflet is not available in print. Download it as a PDF or visit our website to view all our AML information to download.
Acute myeloid leukaemia (AML) is a fast-growing blood cancer that involves the white blood cells. Liposomal daunorubicin + cytarabine is a combination of medicines that can be used to treat AML.
We cover what liposomal daunorubicin + cytarabine is, who might have it and how to have it. We also cover its main side effects and any special precautions you may need to take while you’re on it.
Support Leukaemia Care with a donation
Every donation enables us to support anybody affected by a leukaemia diagnosis
Enter Amount
British Pound | £GBP
£
- Choosing a selection results in a full page refresh.
- Opens in a new window.